We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · January 06, 2020

Impact of the Number of Prior Chemotherapy Regimens on Outcomes of Metastatic Breast Cancer Treated With Eribulin

The Breast Journal

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Breast Journal
Impact of the Number of Prior Chemotherapy Regimens on Outcomes for Patients With Metastatic Breast Cancer Treated With Eribulin: A Post Hoc Pooled Analysis
Breast J 2019 Nov 29;[EPub Ahead of Print], J Cortes, C Twelves

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading